1. Home
  2. CVKD vs POCI Comparison

CVKD vs POCI Comparison

Compare CVKD & POCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • POCI
  • Stock Information
  • Founded
  • CVKD 2022
  • POCI 1982
  • Country
  • CVKD United States
  • POCI United States
  • Employees
  • CVKD N/A
  • POCI N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CVKD Health Care
  • POCI Health Care
  • Exchange
  • CVKD Nasdaq
  • POCI Nasdaq
  • Market Cap
  • CVKD 26.3M
  • POCI 27.2M
  • IPO Year
  • CVKD 2023
  • POCI N/A
  • Fundamental
  • Price
  • CVKD $14.01
  • POCI $5.38
  • Analyst Decision
  • CVKD Strong Buy
  • POCI
  • Analyst Count
  • CVKD 2
  • POCI 0
  • Target Price
  • CVKD $46.00
  • POCI N/A
  • AVG Volume (30 Days)
  • CVKD 70.3K
  • POCI 19.0K
  • Earning Date
  • CVKD 11-07-2024
  • POCI 11-14-2024
  • Dividend Yield
  • CVKD N/A
  • POCI N/A
  • EPS Growth
  • CVKD N/A
  • POCI N/A
  • EPS
  • CVKD N/A
  • POCI N/A
  • Revenue
  • CVKD N/A
  • POCI $18,980,148.00
  • Revenue This Year
  • CVKD N/A
  • POCI N/A
  • Revenue Next Year
  • CVKD N/A
  • POCI N/A
  • P/E Ratio
  • CVKD N/A
  • POCI N/A
  • Revenue Growth
  • CVKD N/A
  • POCI N/A
  • 52 Week Low
  • CVKD $5.40
  • POCI $3.47
  • 52 Week High
  • CVKD $32.55
  • POCI $6.90
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 43.74
  • POCI 62.87
  • Support Level
  • CVKD $15.52
  • POCI $4.45
  • Resistance Level
  • CVKD $19.97
  • POCI $5.35
  • Average True Range (ATR)
  • CVKD 1.80
  • POCI 0.46
  • MACD
  • CVKD -0.44
  • POCI 0.13
  • Stochastic Oscillator
  • CVKD 0.17
  • POCI 100.00

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

Share on Social Networks: